In simple terms, a methylation process needs to be stopped or modified to prevent successful replication of HSV infected cells. For this purpose, the the methylation inhibitor adenosine dialdehyde or a possible analog can be utilized for the treatment and prevention of HSV-1. If this can be successfully achieved, it would become possible to prevent further herpes replication and outbreaks. [...]
|
|||||
|
Scientists discovered a new way for the body’s immune system to fight the virus responsible for cold sores: Type 1 herpes simplex (HSV-1). A group of virologists from the University of Montreal in partnership with American counterparts, have identified a cellular activity that detects and combats the herpes virus. [...] Potential good news for herpes sufferers comes after Australian group Starpharma Holdings Ltd recently announced the successful completion of a fourth set of patient trials of VivaGel®, a topical microbicide being developed for the prevention of HIV and HSV-2 herpes virus infection. [...] A 56 year old San Francisco woman has been awarded a $7 million personal injury payout after contracting genital herpes from her 77 year old lover. [...] AlphaVax, the biotechnology company, has signed a $20 million partnership deal with pharmaceutical company Novartis to develop an experimental herpes cure vaccine for the cytomegalovirus, a type of herpes virus. [...] |
|
||||
|
Copyright © 2012 Herpes News - All Rights Reserved Bad Behavior has blocked 77 access attempts in the last 7 days. |
|||||
